IQSEC1 and mood disorder: The most significant gene from the analysis comparing responders and non-responders, IQSEC1, has been linked to treatment response to antidepressant medication at the genetic level (Garriock et al., 2010), as well as to high-risk individuals prone to developing mood disorders in a DNA methylation study (Walker et al., 2016).